The Food and Drug Administration is investigating whether CAR-T immunotherapies can cause lymphoma in some patients after it received reports of serious adverse events in clinical trials and post-marketing studies.
FDA Probes Safety of CAR-T Therapies
Comment
Show comments
Hide Comments
